AddLife AB Share Price

Equities

ALIF B

SE0014401378

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm 16:29:48 29/05/2024 BST 5-day change 1st Jan Change
111.5 SEK -0.89% Intraday chart for AddLife AB -1.50% +1.92%

Financials

Sales 2024 * 10.3B 965M 75.97B Sales 2025 * 10.84B 1.02B 80.01B Capitalization 13.59B 1.27B 100B
Net income 2024 * 265M 24.84M 1.96B Net income 2025 * 429M 40.21M 3.17B EV / Sales 2024 * 1.79 x
Net Debt 2024 * 4.84B 453M 35.7B Net Debt 2025 * 3.85B 361M 28.44B EV / Sales 2025 * 1.61 x
P/E ratio 2024 *
51.8 x
P/E ratio 2025 *
32 x
Employees 2,289
Yield 2024 *
0.77%
Yield 2025 *
1.18%
Free-Float 87.94%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.02%
1 week-1.50%
Current month+8.67%
1 month+8.89%
3 months+11.39%
6 months+13.83%
Current year+1.92%
More quotes
1 week
110.10
Extreme 110.1
118.50
1 month
99.85
Extreme 99.85
118.50
Current year
94.65
Extreme 94.65
118.50
1 year
54.75
Extreme 54.75
143.40
3 years
54.75
Extreme 54.75
395.00
5 years
52.25
Extreme 52.25
395.00
10 years
24.25
Extreme 24.25
395.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 31/12/21
Director of Finance/CFO - 31/12/21
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 31/12/20
Chairman 57 04/03/15
Director/Board Member 69 31/12/14
More insiders
Date Price Change Volume
29/05/24 111.5 -0.89% 121 504
28/05/24 112.5 -3.85% 81,909
27/05/24 117 +4.46% 90,749
24/05/24 112 -1.06% 37,565
23/05/24 113.2 0.00% 52,368

Delayed Quote Nasdaq Stockholm, May 29, 2024 at 04:29 pm

More quotes
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
112.5 SEK
Average target price
137 SEK
Spread / Average Target
+21.78%
Consensus
  1. Stock Market
  2. Equities
  3. ALIF B Stock